![](/img/cover-not-exists.png)
Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer
Mercadé, E., Cascalló, M., Carrió, M., Calbó, J., Gómez-Treviño, A., Fillat, C., Gómez-Foix, A. M., Mazo, A.Volume:
12
Language:
english
Journal:
Annals of Oncology
DOI:
10.1023/a:1011177223129
Date:
March, 2001
File:
PDF, 5.92 MB
english, 2001